WHO naming stem · suffix · 222 listed names
-tinib
This page was written with AI.
tyrosine kinase inhibitors
Where it sits in a name
WHO writes the stem as -tinib. So the letters tinib sit at the end of the name (…tinib).
All 222 names WHO lists under -tinib
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 75 of 222 names appear in these lists: 72 in the US list (FDA Drugs@FDA) and 64 in the EU central list (EMA); 61 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- abivertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- abrocitinibUS brands: CIBINQOEU (central) brands: Cibinqo
- acalabrutinibUS brands: CALQUENCEEU (central) brands: Calquence
- adrixetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- afatinibUS brands: GILOTRIFEU (central) brands: Giotrif
- alectinibUS brands: ALECENSAEU (central) brands: Alecensa
- altiratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amuvatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anizatrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ansornitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atinvicitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atuzabrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aumolertinibUS brands: none foundEU (central) brands: Aumseqa
- avapritinibUS brands: AYVAKITEU (central) brands: Ayvakyt
- avutometinibEU (central) brands: none found
- axitinibUS brands: INLYTA
- bafetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- baricitinibUS brands: OLUMIANTEU (central) brands: Olumiant
- befotertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- belizatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bemcentinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- beprocitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bezuclastinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- binimetinibUS brands: MEKTOVIEU (central) brands: Mektovi
- boditrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bosutinibUS brands: BOSULIFEU (central) brands: Bosulif
- branebrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brigatinibUS brands: ALUNBRIGEU (central) brands: Alunbrig
- cabozantinibUS brands: RESNIBEN
- canertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- capmatinibUS brands: TABRECTAEU (central) brands: Tabrecta
- catequentinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cerdulatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ceritinibUS brands: ZYKADIAEU (central) brands: Zykadia
- cobimetinibUS brands: COTELLICEU (central) brands: Cotellic
- conteltinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- crizotinibUS brands: XALKORIEU (central) brands: Xalkori
- dacomitinibEU (central) brands: Vizimpro
- dalmelitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- darizmetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dasatinibEU (central) brands: Dasatinib Accord Healthcare, Sprycel, Dasatinib Accord (withdrawn), Dasatinib Accordpharma (withdrawn)
- decernotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- defactinibEU (central) brands: none found
- delgocitinibUS brands: ANZUPGOEU (central) brands: Anzupgo
- denfivontinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- derazantinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- deucravacitinibUS brands: SOTYKTUEU (central) brands: Sotyktu
- deuruxolitinibUS brands: LEQSELVIEU (central) brands: none found
- dovitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dubermatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ebezotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- edicotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- edralbrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elenestinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elsubrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elzovantinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emzeltrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ensartinibUS brands: ENSACOVEEU (central) brands: none found
- entospletinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- entrectinibUS brands: ROZLYTREKEU (central) brands: Rozlytrek
- epertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- erdafitinibUS brands: BALVERSAEU (central) brands: Balversa
- erlotinibEU (central) brands: Tarceva
- evobrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- famitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fedratinibUS brands: INREBICEU (central) brands: Inrebic
- fenebrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- filgotinibUS brands: none foundEU (central) brands: Jyseleca
- fisogatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- flumbatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- foretinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fosifidancitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fostamatinibUS brands: TAVALISSEEU (central) brands: Tavlesse
- fruquintinibUS brands: FRUZAQLAEU (central) brands: Fruzaqla
- futibatinibUS brands: LYTGOBIEU (central) brands: Lytgobi
- gandotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gefitinibUS brands: IRESSA
- gemnelatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gilteritinibUS brands: XOSPATAEU (central) brands: Xospata
- glesatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- golidocitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- golvatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gumarontinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gunagratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gusacitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ibrutinibUS brands: IMBRUVICAEU (central) brands: Imbruvica
- ifebemtinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ifidancitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ilginatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ilunocitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imatinibEU (central) brands: Glivec, Imatinib Accord, Imatinib Teva, Imatinib Actavis (withdrawn), Imatinib Koanaa (withdrawn), Imatinib medac (withdrawn), Imatinib Teva B.V. (withdrawn)
- infigratinibEU (central) brands: none found
- itacitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ivarmacitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- izencitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lapatinibUS brands: TYKERBEU (central) brands: Tyverb
- larotrectinibUS brands: VITRAKVIEU (central) brands: Vitrakvi
- lazertinibUS brands: LAZCLUZEEU (central) brands: Lazcluze
- lenvatinibUS brands: LENVIMA
- lestaurtinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- linsitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lirafugratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lorlatinibUS brands: LORBRENAEU (central) brands: Lorviqua
- lorpucitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- luxeptinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- masitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mavelertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- merestinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mifanertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- milrebrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirdametinibUS brands: GOMEKLIEU (central) brands: Ezmekly
- mivavotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mobocertinibEU (central) brands: none found
- momelotinibUS brands: OJJAARAEU (central) brands: Omjjara
- mubritinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naquotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- narmafotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nazartinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nemtabrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- neratinibUS brands: NERLYNXEU (central) brands: Nerlynx
- nezulcitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nilotinib
- nimucitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oclacitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olafertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olverembatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- orantinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- orelabrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- osimertinibUS brands: TAGRISSOEU (central) brands: Tagrisso
- pacritinibUS brands: VONJOEU (central) brands: none found
- paltimatrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pamufetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- peficitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pegcantratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pelitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pemigatinibUS brands: PEMAZYREEU (central) brands: Pemazyre
- pexidartinibUS brands: TURALIOEU (central) brands: none found
- pexmetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pirtobrutinibUS brands: JAYPIRCAEU (central) brands: Jaypirca
- ponatinibUS brands: ICLUSIGEU (central) brands: Iclusig
- poseltinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- povorcitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- poziotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pralsetinibUS brands: GAVRETO
- pumecitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quizartinibUS brands: VANFLYTAEU (central) brands: Vanflyta
- radotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ralimetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rebastinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- refametinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- remibrutinibUS brands: RHAPSIDOEU (central) brands: Rhapsido
- repotrectinibUS brands: AUGTYROEU (central) brands: Augtyro
- resencatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rezivertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rilzabrutinibUS brands: WAYRILZEU (central) brands: Wayrilz
- ripretinibUS brands: QINLOCKEU (central) brands: Qinlock
- risvodetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ritlecitinibUS brands: LITFULOEU (central) brands: Litfulo
- roblitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rociletinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rogaratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ropsacitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rovadicitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruserontinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruxolitinib
- sacibertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sapitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- saracatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- savolitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- selitrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- selpercatinibUS brands: RETEVMOEU (central) brands: Retsevmo
- selumetinibUS brands: KOSELUGOEU (central) brands: Koselugo
- seralutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sitravatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sofnobrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- solcitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sotuletinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- spebrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sunitinibUS brands: SUTENT
- sunvozertinibUS brands: ZEGFROVYEU (central) brands: none found
- surufatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- taletrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tamnorzatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tandutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tarloxotinib bromideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tasurgratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tepotinibUS brands: TEPMETKOEU (central) brands: Tepmetko
- tesevatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tinengotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tirabrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tivantinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tofacitinibEU (central) brands: Xeljanz
- tolebrutinibUS brands: none foundEU (central) brands: Cenrifki
- trametinibUS brands: MEKINIST
- tucatinibUS brands: TUKYSAEU (central) brands: Tukysa
- tunlametinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tuspetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tuxobertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- unecritinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- upadacitinibEU (central) brands: Rinvoq
- utatrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vamotinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- varlitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vebreltinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vecabrutinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vepafestinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vimseltinibUS brands: ROMVIMZAEU (central) brands: Romvimza
- vodobatinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- xiliertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zanubrutinibUS brands: BRUKINSAEU (central) brands: Brukinsa
- zanzalintinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zapnometinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zasocitinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zeteletinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zidesamtinibUS brands: JIDEYTROEU (central) brands: none found
- zipalertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zoligratinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zongertinibUS brands: HERNEXEOSEU (central) brands: none found
- zorifertinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zunsemetinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zurletrectinibNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
afatinib
Listed INNCarries the WHO stem -tinib
- -tinibend of the nameWHO lists it hereWHO definition: tyrosine kinase inhibitors
“afatinib” is an INN that WHO lists under -tinib in the 2024 stem book. WHO’s 2024 stem book lists “afatinib” under -ertinib as a name of the same group of substances in which the stem is not used (group c).
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -tinib (Part II B) and the 222 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.